Health Care·Biotechnology·$351.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +0.33% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.33% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, indicating a commitment to long-term growth strategies despite not providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on driving long-term growth.
AbbVie's earnings report showed a positive surprise on EPS, which indicates better-than-expected profitability. However, the stock dropped by 6.28% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious about the company's future performance without clearer expectations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CATERPILLAR INC
Oct 25, 2016